Penicillin-induced hemolytic anemia and acute hepatic failure following treatment of tetanus in a horse.

This research article describes a case where a horse treated for tetanus using penicillin and tetanus antitoxin developed severe hemolytic anemia and later acute hepatic failure, possibly caused by the treatments used.

Case Description

• The research article investigates a case where a horse under treatment for tetanus experienced severe side effects. The horse was treated with intravenous penicillin and tetanus antitoxin.
• As a reaction to the treatment, the horse developed acute, severe hemolytic anemia – a condition where red blood cells are destroyed faster than they can be produced.

Diagnostic Findings

• During treatment, diagnostic tests indicated the horse had developed a high titer – an indicator of the level of antibodies in a patient’s blood – of IgG anti-penicillin antibody. This likely caused the hemolytic anemia as the anti-penicillin antibodies could have been destroying the horse’s own red blood cells.
• A direct antiglobulin test (DAT) was also positive. This test is a measure of autoimmune hemolytic anemia, suggesting that the horse’s immune response to the penicillin triggered the severe anemia.

Outcome and Interpretation

• Despite the severe anemia, the horse eventually recovered from both the tetanus and the penicillin-induced hemolytic anemia.
• However, the horse later developed acute hepatic failure, a life-threatening condition where a large portion of the liver loses its ability to function. The report suggests that this was probably a result from the administration of the tetanus antitoxin, which was of equine origin. The horse’s body may have recognized this antitoxin as something foreign, leading to an immune reaction that damaged its liver.